1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Nexgard Spectra

Discussion in 'MWI' started by anonymous, Feb 10, 2016 at 6:16 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    when?
     

  2. anonymous

    anonymous Guest

    2017-2018 maybe ? If The new BI overlords don't kill it
     
  3. anonymous

    anonymous Guest

    2017
     
  4. anonymous

    anonymous Guest

    Never. Failed licensure in US 2 months ago.
     
  5. anonymous

    anonymous Guest

    Haha. Thanks Mr. FDA. Coming soon to a clinic near you.....